Securities code: 300888 securities abbreviation: Winner Medical Co.Ltd(300888) Announcement No.: 2022-005 Winner Medical Co.Ltd(300888)
Announcement on the progress of repurchasing shares of the company
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Winner Medical Co.Ltd(300888) (hereinafter referred to as “the company”) convened the third meeting of the third board of directors and the third meeting of the third board of supervisors on September 17, 2021 to consider and adopt the proposal on share repurchase scheme. Based on the confidence in future development and the judgment of its own value, in order to enhance the confidence of investors and further build a more stable and high-quality management team, Establish and improve the company’s long-term incentive mechanism, fully mobilize the enthusiasm of the management and core backbone, improve team cohesion, effectively closely combine the interests of shareholders, the company and the personal interests of core employees, and promote the long-term sustainable development of the company. The company plans to use its own funds of RMB 300-500 million to repurchase the company’s shares at a price of no more than 116 yuan / share, Based on the above repurchase amount range and repurchase price ceiling, the number of repurchases shall be no less than 2586200 shares and no more than 4310300 shares, accounting for no less than 0.6064% and no more than 1.0107% of the total share capital of the company. For details, please refer to the announcement on share repurchase scheme disclosed by the company on September 22, 2021 and the repurchase report disclosed on September 29, 2021.
According to the relevant provisions of the detailed rules for the implementation of share repurchase by listed companies of Shenzhen Stock Exchange, the progress of share repurchase by the company is disclosed as follows:
1、 Progress of share repurchase
As of January 31, 2022, the company has repurchased 3280091 shares of the company through centralized bidding trading through the special securities repurchase account, accounting for 0.7691% of the total share capital of the company. The maximum transaction price is 82.42 yuan / share, the minimum transaction price is 73.91 yuan / share, and the total transaction amount is 257949867 yuan (excluding transaction costs). This share repurchase meets the requirements of relevant laws and regulations, departmental rules, normative documents, business rules and the company’s share repurchase plan.
2、 Other instructions
(I) the time, price and quantity of the company’s initial share repurchase comply with the relevant provisions of Articles 17, 18 and 19 of the detailed rules for the implementation of share repurchase by listed companies of Shenzhen Stock Exchange.
1. The company has not repurchased the company’s shares within the following periods:
(1) Within 10 trading days before the announcement of the company’s regular report, performance forecast or performance express;
(2) From the date of occurrence of major events that may have a significant impact on the company’s stock trading price or in the process of decision-making to two trading days after disclosure according to law;
(3) Other circumstances prescribed by the CSRC and Shenzhen Stock Exchange.
2. The company has not entrusted to buy back shares at the following trading hours:
(1) Opening call auction;
(2) Within half an hour before the closing;
(3) There is no limit on the rise and fall of stock prices
The price of repurchased shares is not the price limited by the trading increase of the company’s shares on the same day.
3. The Company repurchased its shares for the first time on September 28, 2021. The cumulative trading volume of the company’s shares in the five trading days before the date of the first repurchase of shares was 11893150 shares. The number of repurchased shares of the company in every five trading days did not exceed 25% (2973287 shares) of the cumulative trading volume of the company’s shares in the five trading days before the date of the first repurchase of shares.
(II) the company will continue to implement the repurchase plan during the repurchase period in combination with the market situation, and timely perform the obligation of information disclosure in accordance with the requirements of relevant laws and regulations, departmental rules, normative documents and business rules. It is hereby announced.
Winner Medical Co.Ltd(300888) board of directors February 9, 2002
